Page 387 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

Ophthalmologic and Neuro-Ophthalmologic Aspects of Vasculitides 361

[42] Kaushik S, et al. Retinal arterial occlusion in Takayasu?s arteritis. Indian J.
Ophthalmol., 2005; 53:194-196.

[43] Shailaja S, Vivek G, Shetty R, et al. „Eye is a window the pulse?: bilateral ocular
ischaemic syndrome as a presenting manifestation of Takayasu arteritis. BMJ Case
Reports, 2013.

[44] Demir MN, Hazirolan D, Altiparmak UE, et al. Takayasu?s disease and secondary
ocular ischemic syndrome. J. Pediatr. Ophthalmol. Strabismus, 2010; 47:54-57.

[45] Pelegrin T, Mesquida M, Rey A, et al. Blind runner. Surv. Ophthalmol. 2012; 57:486-
494.

[46] Baba T, Itakura K, Tanaka R, et al. Importance of fluorescein angiographic study in
evaluation early retinal changes in Takayasu disease. Jpn. J. Ophthalmol., 1999:43:546-
552.

[47] Jales-Neto LH, Levy-Neto M, Bonfa E, et al. Juvenile-onset Takayasu arteritis: peculiar
vascular involvement and more refractory disease. Scand. J. Rheumatol., 2010; 39:506-
510.

[48] Ishikawa K. Natural history and classification of occlusive thromboaortopathy
(Takayasu?s disease). Circulation, 1978: 57:27-35.

[49] de Souza SW, Machado NP, Pereira VM, et al. Antiplatelet therapy for the prevention
of arterial ischemic events in Takayasu arteritis. Circ. J., 2010; 74:1236-1241.

[50] Leonard TJK, Sanders MD. Ischaemic optic neuropathy in pulseless disease. Br. J.
Ophthal., 1983; 67:389-392.

[51] Lewis JR, Glaser JS, Schatz NJ, et al. Pulseless (Takayasu) Disease with Ophthalmic
Manifestations. Journal of Clinical Neuro-Ophthalmology, 1993; 13:242-249.

[52] Ormerod AS, Cook MC. Epidemiology of primary systemic vasculitis in the Australian
Capital Territory and south-eastern New South Wales. Intern. Med. J., 2008; 38:816-23.

[53] Mohammad AJ, Jacobsson LT, Mahr AD. Prevalence of Wegener?s granulomatosis,
microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a
defined population in southern Sweden. Rheumatology, 2007; 46:1329-1337.

[54] McMahon BJ, Heyward WL, Templin DW, et al. Hepatitis B-associated polyarteritis
nodosa in Alaskan Eskimos: clinical and epidemiologic features and long-term follow
up. Hepatology, 1989; 9:97-101.

[55] Bae YD, Choi HJ, Lee JC, et al. Clinical features of polyarteritis nodosa in Korea. J.
Korean Med. Sci., 2006; 21:591-595.

[56] Mahr A, Guillevin L, Poissonnet M, et al. Prevalences of polyarteritis nodosa,
microscopic polyangiitis, Wegener?s granulomatosis, and Churg-Strauss syndrome in a
French urban multiethnic population in 2000: A capture-recapture estimate. Arthritis
Rheum. 2004; 51:92-99.

[57] Goar EL, Smith LS. Polyarteritis Nodosa of the Eye. Trans Am. Ophthalmol. Soc.,
1951; 49:37-46.

[58] Nanjiani MR. Ocular manifestations of polyarteritis nodosa. Brit. J. Ophthalmol., 1967;
51:696-697.

[59] Morgan C, Foster S, D?Amico D, et al. Retinal vasculitis in polyarteritis nodosa. Retina,
1986; 6:205-209.

[60] Purcell JJ, Birkenkamp R, Tsai CC. Conjunctival lesions in periarteritis nodosa. A
clinical and immunopathologic study. Arch. Ophthalmol., 1984; 102:736-738.

Complimentary Contributor Copy